{
  "slug": "driving-after-cannabis",
  "question": "What are the odds of causing a fatal crash by driving within a few hours of using cannabis?",
  "category": "transport",
  "tags": [
    "substance-use"
  ],
  "no_reliable_estimate": false,
  "perceived": {
    "description": "Most regular cannabis users believe driving stoned is meaningfully safer than driving drunk, and a substantial minority believe it is safe or even improves their driving. Self-report surveys in legal-cannabis US states find that roughly 30-50% of past-month cannabis users have driven within two hours of use, and most of those describe themselves as cautious or unaffected. The subjective experience of acute cannabis impairment is qualitatively different from alcohol: drivers typically feel slower, more focused, and self-correctingly conservative — they drive more carefully on the straightaways and miss the high-attention edge cases (lane departures, sudden brake events, peripheral movement) where the per-trip crash risk actually lives.\n",
    "rough_estimate": "most regular cannabis users believe driving stoned is far safer than driving drunk",
    "kind": "intuition"
  },
  "native": {
    "display": "~4 per 100,000 trips result in a fatal crash for a driver within ~2 hours of cannabis use at ~5 ng/mL blood THC (≈2× the sober-driver rate)",
    "numerator": 4,
    "denominator": 100000,
    "unit": "per cannabis-impaired trip (fatal crash involvement)",
    "population": "US adult driver within ~2 hours of cannabis use at acute-effect concentrations (≥5 ng/mL whole-blood THC), per-trip crash involvement rate derived from Albrecht 2025 meta-regression applied to NHTSA per-trip baseline"
  },
  "normalized": {
    "lifetime_us_adult": 0.019,
    "display": "~1 in 52 lifetime (driver who drives within 2 hours of cannabis use ~monthly)",
    "log_value": -1.721,
    "assumptions": "The US population-average per-trip fatal-crash probability for a sober driver is approximately 1 in 50,000 (the baseline used in the driving-at-0.1pct-bac entry, derived from FARS and NHTSA per-trip estimates). Albrecht et al. 2025 (Drug Science, Policy and Law) pooled culpability studies in a dose-response meta-regression and found crash-culpability risk roughly doubles at ~5 ng/mL whole-blood THC and roughly quadruples at ~10 ng/mL; below ~1.5 ng/mL the increase is not distinguishable from baseline. Applying a 2× per-trip multiplier at acute-effect concentrations gives ~1 in 25,000 per cannabis-impaired trip. For a driver who operates within two hours of cannabis use roughly monthly (12 trips/year over 40 years ≈ 480 impaired trips), cumulative probability is 1 − (1 − 1/25000)^480 ≈ 0.019, or roughly 1 in 52. The uncertainty band reflects two main sources: the Rogeberg & Elvik 2016 pooled adjusted OR is only 1.36 (so weekly casual use yields a lower estimate than the Albrecht acute-dose point), while the European DRUID study found OR ≈ 6.6 at ≥5 ng/mL (closer to 0.15% BAC), which would push the high-end estimate to ~1 in 9.\n",
    "uncertainty": {
      "low": 0.006,
      "high": 0.08
    },
    "scope": "activity_specific_lifetime"
  },
  "sources": [
    {
      "url": "https://journals.sagepub.com/doi/10.1177/20503245251323344",
      "title": "Dose-response relationship between blood concentrations of THC and crash culpability risk: An updated meta-regression of culpability studies",
      "publisher": "Albrecht, Hasan, Kekez, Zhou — Drug Science, Policy and Law",
      "source_type": "peer_reviewed",
      "statistic": "Crash culpability risk increases with rising whole-blood THC concentration, with an inflection around 1.5-3.0 ng/mL where risk begins to rise above baseline; risk approximately doubles at ~5 ng/mL and approximately quadruples at ~10 ng/mL. Below ~1.5 ng/mL culpability is statistically indistinguishable from baseline (<30% increase).\n",
      "excerpt": "\"Crash culpability risk increases with increasing THC concentration, with an inflection around 1.5-3.0 ng/ml where risk begins to increase... a doubling of culpability risk around 5 ng/ml and a potential quadrupling of risk around 10 ng/ml.\"\n",
      "source_date": "2025-03-01",
      "source_accessed": "2026-05-25",
      "archive_url": "http://web.archive.org/web/20250407122737/https://journals.sagepub.com/doi/10.1177/20503245251323344",
      "calculation_notes": "Albrecht 2025 is the most recent dose-response meta-regression and the cleanest source for translating a blood THC concentration into a per-trip crash-culpability multiplier. The doubling at ~5 ng/mL whole blood is used here as the headline per-trip risk multiplier for \"driving within ~2 hours of typical inhaled cannabis use\" (which produces peak THC concentrations in roughly that range). The quadrupling at ~10 ng/mL and Rogeberg 2016 pooled 1.36 OR bracket the uncertainty band.\n"
    },
    {
      "url": "https://onlinelibrary.wiley.com/doi/abs/10.1111/add.13347",
      "title": "The effects of cannabis intoxication on motor vehicle collision revisited and revised",
      "publisher": "Rogeberg, O. & Elvik, R. — Addiction 111(8):1348-1359",
      "source_type": "peer_reviewed",
      "statistic": "Pooled odds ratio across 28 estimates from 21 observational studies for acute cannabis use and motor-vehicle collision involvement was 1.36 (95% CI 1.15-1.61); roughly half of earlier higher estimates from the Asbridge 2012 BMJ meta-analysis disappear after correcting for confounding and methodological inconsistencies.\n",
      "excerpt": "\"Our updated meta-analysis suggests that the increase in crash risk caused by cannabis intoxication is moderate, around 20-30%, much smaller than that of drink-driving and similar in magnitude to that of driving with a blood alcohol concentration between 0.01% and 0.05%.\"\n",
      "source_date": "2016-08-01",
      "source_accessed": "2026-05-25",
      "archive_url": "http://web.archive.org/web/20230606233509/https://onlinelibrary.wiley.com/doi/abs/10.1111/add.13347",
      "calculation_notes": "Rogeberg & Elvik 2016 (DOI 10.1111/add.13347, PMID 26878835) is the most methodologically careful pooled estimate available. It used 28 estimates from 21 observational studies (case-control and culpability designs) and explicitly corrected for the confounding by age, sex, and time-of-day that the Asbridge 2012 BMJ meta-analysis partially missed. The 1.36 odds ratio is the low-end pooled multiplier used in the uncertainty band; it represents the \"any cannabis-positive driver\" average, dominated by drivers with residual THC from prior days rather than acute peak concentrations. Albrecht's 5 ng/mL doubling is the appropriate reference for acute post-use trips and anchors the headline.\n"
    },
    {
      "url": "https://www.nhtsa.gov/staticfiles/nti/pdf/812117-Drug_and_Alcohol_Crash_Risk.pdf",
      "title": "Drug and Alcohol Crash Risk (Research Note, DOT HS 812 117)",
      "publisher": "Compton, R.P. & Berning, A. — National Highway Traffic Safety Administration",
      "source_type": "govt_report",
      "statistic": "The unadjusted odds ratio for crash involvement among THC-positive drivers in the Virginia Beach case-control study was 1.25; after adjustment for age, sex, race/ethnicity, and alcohol concentration the odds ratio dropped to 1.00 (95% CI 0.77-1.31), indicating no statistically significant elevation. The same study found 0.08% BAC associated with adjusted OR of 3.93 and 0.15% BAC with adjusted OR of 12.04.\n",
      "excerpt": "\"After adjustment for age, gender, race/ethnicity, and alcohol use, the odds of being a crash-involved driver was not statistically different from that of a control driver who tested positive for THC (OR=1.00, 95% CI 0.77-1.31).\"\n",
      "source_date": "2015-02-01",
      "source_accessed": "2026-05-25",
      "archive_url": "http://web.archive.org/web/20230111133721/https://www.nhtsa.gov/staticfiles/nti/pdf/812117-Drug_and_Alcohol_Crash_Risk.pdf",
      "calculation_notes": "The 2015 NHTSA Virginia Beach study is the largest US case-control study of drug-positive driving and is frequently cited as evidence that cannabis-impaired driving carries no elevated risk after controlling for confounders. Methodologists (Rogeberg, Albrecht, Compton) note that the null result reflects the dominance of residual-THC-positive drivers in the cannabis-positive group; separating acute-use from residual-positive cases (which the blood-concentration meta-regressions do) recovers a measurable dose-response signal. Used here as the lower bound on the \"any THC positive\" risk multiplier and as evidence that the headline number depends strongly on how the impaired population is defined.\n"
    }
  ],
  "comparison_anchors": [
    {
      "label": "Death in a car crash (lifetime, US adult, population average)",
      "lifetime_us_adult": 0.0108
    },
    {
      "label": "Causing a fatal crash at 0.10% BAC (~monthly, lifetime)",
      "lifetime_us_adult": 0.062
    },
    {
      "label": "Causing a fatal crash while drowsy (~monthly, lifetime)",
      "lifetime_us_adult": 0.038
    }
  ],
  "personal_factor_multipliers": [
    {
      "factor": "drives within 2 hours of cannabis use only a few times per year",
      "multiplier": 0.2,
      "notes": "Rare acute-use trips compress cumulative exposure sharply."
    },
    {
      "factor": "drives within 2 hours of cannabis use ~monthly",
      "multiplier": 1,
      "notes": "Baseline assumption for the headline lifetime estimate."
    },
    {
      "factor": "drives within 2 hours of cannabis use ~weekly",
      "multiplier": 4,
      "notes": "52 trips/year over 40 years (~2,080 impaired trips) raises cumulative probability roughly 4x."
    },
    {
      "factor": "high-dose edibles (peak concentration ~10 ng/mL or higher)",
      "multiplier": 2,
      "notes": "Albrecht 2025 dose-response: roughly 4x per-trip at ~10 ng/mL vs ~2x at ~5 ng/mL."
    },
    {
      "factor": "combined cannabis + any alcohol use",
      "multiplier": 5,
      "notes": "Multiple culpability studies (Compton 2015, DRUID) find super-additive risk when cannabis combines with alcohol; combined-substance ORs typically exceed the sum of components."
    }
  ],
  "short_label": "Driving after cannabis",
  "myth_framing": "underrated",
  "outcome_severity": "fatal",
  "exposure_pattern": "recurring",
  "outcome_type": "death",
  "valence": "negative",
  "caveats": "The cannabis-driving evidence base has unusually wide spread because the published estimates depend heavily on how the impaired population is defined. \"THC-positive\" includes drivers who used cannabis days earlier and retain detectable but non-impairing residual concentrations; \"acute use\" means within roughly 1-3 hours of inhalation or 2-4 hours of edible peak. Pooled \"any positive\" ORs (Rogeberg 1.36, Compton 1.00 adjusted) are dominated by the residual group and underestimate acute-use risk. Dose-response meta-regressions (Albrecht 2025, the DRUID studies) isolate the acute-use signal and find substantially higher per-trip risk at concentrations consistent with recent inhalation. The headline 1 in 52 estimate uses the acute- use Albrecht multiplier at ~5 ng/mL, which corresponds to typical post-inhalation peak concentrations but is conservative for high-dose edibles or concentrate use. The combination with even modest alcohol use is super-additive and not captured in the headline figure. Compared with the 0.10% BAC entry, the per-trip risk multiplier is smaller (~2× vs ~5.5×) but the per-event frequency for regular cannabis consumers can be higher (weekly is more common than weekly drunk driving), so the lifetime totals end up closer than the per-trip comparison would suggest.\n",
  "quality_score": {
    "d1": 4,
    "d2": 5,
    "d3": 5,
    "d4": 4,
    "d5": 5,
    "d6": 5,
    "d7": 4,
    "d8": 5,
    "avg": 4.625,
    "scored_by": "claude-code-8d",
    "scored_at": "2026-05-25",
    "methodology_version": "fears-8d-v1"
  },
  "reviewer": "8d-eval-independent-2026-05-25",
  "last_reviewed": "2026-05-25",
  "reviewed": true,
  "generated_at": "2026-05-25",
  "image": {
    "alt": "A muted flat vector illustration of a single car steering wheel with a small leaf shape outline beside it, on a pale background."
  },
  "attribution": "Likelier — https://likelier.app",
  "license": "https://creativecommons.org/licenses/by-sa/4.0/",
  "support": "https://buymeacoffee.com/kgluszczyk?via=likelier&utm_content=api-fear-single",
  "canonical_url": "https://likelier.app/driving-after-cannabis"
}